ZA895468B - Stable free radical containing contrast media - Google Patents

Stable free radical containing contrast media

Info

Publication number
ZA895468B
ZA895468B ZA895468A ZA895468A ZA895468B ZA 895468 B ZA895468 B ZA 895468B ZA 895468 A ZA895468 A ZA 895468A ZA 895468 A ZA895468 A ZA 895468A ZA 895468 B ZA895468 B ZA 895468B
Authority
ZA
South Africa
Prior art keywords
stable free
free radical
radical containing
contrast media
containing contrast
Prior art date
Application number
ZA895468A
Other languages
English (en)
Inventor
Ib Leunbach
Leunbach Ib
Original Assignee
Hafslun Nycomed Innovation Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslun Nycomed Innovation Ab filed Critical Hafslun Nycomed Innovation Ab
Publication of ZA895468B publication Critical patent/ZA895468B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA895468A 1988-07-19 1989-07-18 Stable free radical containing contrast media ZA895468B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888817137A GB8817137D0 (en) 1988-07-19 1988-07-19 Compositions

Publications (1)

Publication Number Publication Date
ZA895468B true ZA895468B (en) 1990-04-25

Family

ID=10640699

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895468A ZA895468B (en) 1988-07-19 1989-07-18 Stable free radical containing contrast media

Country Status (13)

Country Link
US (1) US5322065A (xx)
EP (1) EP0351919B1 (xx)
JP (1) JPH03506028A (xx)
AT (1) ATE77755T1 (xx)
AU (1) AU622692B2 (xx)
DE (1) DE68901958T2 (xx)
DK (1) DK8091D0 (xx)
ES (1) ES2033077T3 (xx)
GB (1) GB8817137D0 (xx)
GR (1) GR3005234T3 (xx)
PH (1) PH27247A (xx)
WO (1) WO1990000904A1 (xx)
ZA (1) ZA895468B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819753D0 (en) * 1988-08-19 1988-09-21 Nycomed As Apparatus
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8929300D0 (en) * 1989-12-29 1990-02-28 Instrumentarium Corp Apparatus
GB9024528D0 (en) * 1990-11-12 1991-01-02 Instrumentarium Corp Improvements in and relating to magnetic resonance imaging
US5264204A (en) * 1992-04-30 1993-11-23 Mallinckrodt Medical, Inc. Hydrophilic free radicals for magnetic resonance imaging
DE4328639C2 (de) * 1993-08-23 2002-10-24 Lancaster Group Gmbh Verfahren zur Messung des antioxidativen Potentials der Haut
US5622687A (en) * 1994-11-15 1997-04-22 Molecular Biosystems, Inc. Calixarene conjugates useful as MRI and CT diagnostic imaging agents
WO1997024145A1 (fr) * 1995-12-28 1997-07-10 Daiichi Radioisotope Laboratories, Ltd. Medicaments d'aide au diagnostic
US5978694A (en) * 1997-02-27 1999-11-02 Uri Rapoport Method and apparatus for detecting a magnetically responsive substance
US6278893B1 (en) 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US6185444B1 (en) * 1998-03-13 2001-02-06 Skelscan, Inc. Solid-state magnetic resonance imaging
US6503478B2 (en) 1999-01-13 2003-01-07 Lightouch Medical, Inc. Chemically specific imaging of tissue
US6574496B1 (en) * 1999-05-19 2003-06-03 Amersham Health As Magnetic resonance imaging
US7574248B2 (en) * 2002-05-17 2009-08-11 General Hospital Corporation Method and apparatus for quantitative bone matrix imaging by magnetic resonance imaging
KR20070063504A (ko) 2004-07-30 2007-06-19 지이 헬스케어 에이에스 조성물의 제조 방법, 조성물 및 그의 용도
US20070025918A1 (en) * 2005-07-28 2007-02-01 General Electric Company Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization
US8377419B2 (en) 2005-09-28 2013-02-19 The President And Fellows Of Harvard College Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging
WO2007064226A2 (en) 2005-12-01 2007-06-07 Ge Healthcare As Method of dynamic nuclear polarisation (dnp) using a trityl radical and a paramagnetic metal ion
EP1960001A2 (en) 2005-12-08 2008-08-27 Koninklijke Philips Electronics N.V. System and method for monitoring in vivo drug release using overhauser-enhanced nmr
US20080284429A1 (en) * 2005-12-10 2008-11-20 The President And Fellows Of Harvard College Situ Hyperpolarization of Imaging Agents
US20090252686A1 (en) * 2006-01-11 2009-10-08 President And Fellows Of Harvard College Ex Vivo Hyperpolarization of Imaging Agents
CN101506179B (zh) 2006-08-30 2012-08-22 通用电气医疗集团股份有限公司 动态核极化(dnp)的方法及用于所述方法的化合物和组合物
EP2902041A1 (en) 2007-12-19 2015-08-05 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
DE102008064400A1 (de) 2008-06-02 2009-12-03 Rohde & Schwarz Gmbh & Co. Kg Mikrowellenuntersuchung mit einem Kontrastmittel
US20100092390A1 (en) * 2008-10-09 2010-04-15 President And Fellows Of Harvard College Methods for Making Particles Having Long Spin-Lattice Relaxation Times
EP2476009A1 (en) 2009-09-10 2012-07-18 GE Healthcare UK Limited 13c-mr detection using hyperpolarised 13c-fructose
JP5758982B2 (ja) 2010-04-08 2015-08-05 ブラッコ・イメージング・ソシエタ・ペル・アチオニＢｒａｃｃｏ Ｉｍａｇｉｎｇ Ｓ．Ｐ．Ａ． 過分極基質の製造方法およびｍｒｉのための方法
WO2013053839A1 (en) 2011-10-12 2013-04-18 Bracco Imaging Spa Process for the preparation of hyperpolarized derivatives for use in mri analysis
US9693828B2 (en) 2011-12-05 2017-07-04 Bracco Imaging S.P.A. Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation in MRI analysis
US9925280B2 (en) 2012-04-02 2018-03-27 Bracco Imaging S.P.A. Hyperpolarized amino acids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154857A5 (en) * 1971-09-28 1973-05-18 Commissariat Energie Atomique Deuterated nitroxide radical - tetra methyl 2,2,5,5-aza -1-cyclopentane oxa-3-oxyl-1
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4516075A (en) * 1983-01-04 1985-05-07 Wisconsin Alumni Research Foundation NMR scanner with motion zeugmatography
DE3328365A1 (de) * 1983-08-03 1985-02-21 Schering AG, 1000 Berlin und 4709 Bergkamen Neue diagnostische mittel
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
US4834964A (en) * 1986-03-07 1989-05-30 M.R.I., Inc. Use of charged nitroxides as NMR image enhancing agents for CSF
US4719425A (en) * 1986-04-15 1988-01-12 Scientific Innovations, Inc. NMR imaging method and apparatus
JP2690987B2 (ja) * 1987-06-23 1997-12-17 ハフスルンド・ニユコメド・イノベイション・アクチェボラーグ 磁気共鳴像形成における改良
AU1966188A (en) * 1987-08-07 1989-03-09 Mallinckrodt, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5042488A (en) * 1987-09-29 1991-08-27 The Washington University Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ
US4893627A (en) * 1988-05-26 1990-01-16 The United States Of America As Represented By The United States Department Of Energy Method for nuclear magnetic resonance imaging using deuterum as a contrast agent

Also Published As

Publication number Publication date
DE68901958D1 (de) 1992-08-06
WO1990000904A1 (en) 1990-02-08
DE68901958T2 (de) 1992-12-10
PH27247A (en) 1993-05-03
DK8091A (da) 1991-01-17
JPH03506028A (ja) 1991-12-26
AU3867889A (en) 1990-02-19
GB8817137D0 (en) 1988-08-24
EP0351919A1 (en) 1990-01-24
ATE77755T1 (de) 1992-07-15
DK8091D0 (da) 1991-01-17
ES2033077T3 (es) 1993-03-01
AU622692B2 (en) 1992-04-16
US5322065A (en) 1994-06-21
EP0351919B1 (en) 1992-07-01
GR3005234T3 (xx) 1993-05-24

Similar Documents

Publication Publication Date Title
PH27247A (en) Stable free radical containing contrast media
SG43224A1 (en) Magnetic field generating device used for MRI
ZA92118B (en) Echo contrast media
ITTO910281A0 (it) Procedimento per l'ossidazione di carboidrati
GR3005470T3 (xx)
AR246956A1 (es) Compuesto quelante, un intermediario para preparar el mismo, y un procedimiento para preparar una composicion de medio de contraste.
HUT68299A (en) Preparations containing (s)-(-)-alfa-etil-2-oxo-1-pirrolidine acetamide for the treatment of anxiety
SE9004060D0 (sv) Bensazepin- och bensotiazepin-derivat
DK429089A (da) Alkylbenzylaminer
GR3003327T3 (en) Substituted 1,8-naphthyridine derivatives and fungicides containing them
IL82029A0 (en) Magnetic resonance studies of restricted volumes
IT8420682A1 (it) "Procedimento per il trattamento di articoli di maglieria"
GR81206B (en) Thiolan-2,4-dion-3-carboxamide
EP0522157A4 (en) Novel use of alkanamidocarboxybetaine
AU2396492A (en) Use of persistent free radicals in magnetic resonance imaging
EP0438245A3 (en) Non-magnetic one-component developer
ATE96435T1 (de) Oxiran-phenylester und diese enthaltende fungizide.
EP0377127A3 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel
DE3360671D1 (en) Organophosphate derivatives
HK1000244A1 (en) Use of naphthoxazines
PL288454A2 (en) Device for generation of magnetic field
KR910010898U (ko) 어린이 지능 개발용 요람
EP0239087A3 (en) Process for the stabilization of acicular ferromagnetic chromium dioxide
GB8810128D0 (en) Phospholipids & their use as magnetic resonance imaging contrast agents
HU904898D0 (en) Membranic sterilizing storer for acupuncturel needles made of silicone rubber